Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

DSR-85955 as a new mineralocorticoid receptor antagonist

Nov. 22, 2013

Phase II results for CSL-112 as a potential treatment for atherothrombotic disease

Nov. 22, 2013

Kyowa Hakko Kirin identifies lead compound for colon cancer

Nov. 21, 2013

DS-3078 evaluated in first-in-human advanced solid tumors study

Nov. 21, 2013

F-star generates an Fcab antibody against HER2

Nov. 21, 2013

Jacobus Pharmaceutical presents novel and potent antimalarial agent

Nov. 21, 2013

Innate Pharma initiates program to develop anti-MICA antibody

Nov. 21, 2013

Researchers identify a novel mutation in the HEXB gene associated with Sandhoff disease

Nov. 21, 2013

SUVN-A60203 and its effects on alcohol consumption

Nov. 21, 2013

Clinical results for K-877, a novel PPAR-alpha receptor agonist, presented

Nov. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...